Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics parp'

Search results for: 'research area epigenetics parp'

Items 1-10 of 12

Page
per page
  1. AMI-1
    A1908 AMI-1
    Summary: PRMT1 inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥19.1 mg/mL
  2. EPZ-6438
    A8221 EPZ-6438
     5 Citation
    Summary: EZH2 inhibitor, potent and selective
      ≥28.64 mg/mL
  3. EPZ5676
    A4166 EPZ5676
     1 Citation
    Target: DOT1L
    Summary: DOT1L inhibitor,potent and SAM competitive
      ≥28.15 mg/mL
  4. Histone-H2A-(107-122)-Ac-OH
    A1146 Histone-H2A-(107-122)-Ac-OH
    Summary: Histone-H2A peptide
      ≥176.2 mg/mL
  5. Chaetocin
    A4502 Chaetocin
    Summary: SUV39H1 Inhibitor
      soluble in DMSO
  6. UNC0638
    A1914 UNC0638
     1 Citation
    Summary: G9a/GLP HMTase inhibitor, potent and selective
      ≥25.5 mg/mL
  7. UNC 0646
    A4504 UNC 0646
    Summary: G9a and GLP inhibitor
      ≥24.1 mg/mL
  8. UNC 0224
    A4503 UNC 0224
    Summary: G9a histone methyltransferase inhibitor
      ≥48.6 mg/mL
  9. BIX 01294
    A1909 BIX 01294
    Target: G9a
    Summary: G9a and GLP inhibitor
      ≥24.45 mg/mL
  10. 3-Deazaneplanocin A (DZNep) hydrochloride
    A8182 3-Deazaneplanocin A (DZNep) hydrochloride
     1 Citation
    Target: EZH2
    Summary: SAHH and EZH2 inhibitor
      insoluble in EtOH; ≥14.94 mg/mL

Items 1-10 of 12

Page
per page